Additional Metadata
Persistent URL dx.doi.org/10.1093/annonc/mdy284.020, hdl.handle.net/1765/125537
Journal Annals of Oncology
Citation
Meisel, A, de Wit, R, Oudard, S, Sartor, A.O, Stenner-Liewen, F, Shun, Z. (Z.), … de Bono, J.S. (2018). Association of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel. Annals of Oncology, 29, viii280–viii281. doi:10.1093/annonc/mdy284.020